Related Experiment Video
Updated: Sep 18, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Case Series: Genetic mimics of hypertrophic cardiomyopathy in elderly
Olga S Chumakova1,2, Olga A Drobyazko2, Elena A Stepanova3
1Cardiological Department, Moscow City Clinical Hospital No. 17, Moscow, Russia.
Insights
Hypertrophic cardiomyopathy mimics can be challenging to diagnose, especially in older adults. Genetic testing is crucial for identifying rare conditions like amyloidosis, Fabry disease, and desminopathy, enabling accurate diagnosis and tailored treatments.
Area of Science:
- Cardiology
- Genetics
- Rare Diseases
Background:
- Hypertrophic cardiomyopathy (HCM) is a common genetic heart disorder caused by sarcomeric protein variants.
- A significant percentage of patients with HCM phenotypes may have other underlying genetic conditions.
- Diagnosing these HCM mimics can be difficult, particularly in elderly patients due to subtle extracardiac signs.
Observation:
- This study details three cases mimicking HCM: TTR p.V50M amyloidosis, GLA p.N215S Fabry disease, and DES p.R355* desminopathy.
- Clinical presentation in elderly individuals can obscure underlying syndromic diseases.
- Genetic testing is vital for differentiating HCM from its mimics.
Findings:
- Comprehensive genetic and clinical data were collected for three distinct HCM mimic cases.
- Specific pathogenic nucleotide variants (PNVs) were identified in TTR, GLA, and DES genes.
- The study highlights the diagnostic challenges posed by these rare hereditary conditions.
Implications:
- Accurate genetic diagnosis of HCM mimics is essential for appropriate patient management and treatment.
- Early identification allows for targeted therapies and screening of at-risk family members.
- Understanding these mimics improves diagnostic strategies for complex cardiac phenotypes.
Abstract:
Hypertrophic cardiomyopathy (HCM) is the most prevalent genetic cardiac disorder, primarily driven by pathogenic nucleotide variants (PNVs) in the genes that encode sarcomeric proteins. Such PNVs cause a disruption of cardiomyocytes. Notably, up to 5% of patients with an HCM phenotype may actually have other conditions that mimic HCM. These rarer, predominately hereditary syndromic diseases can be clinically suspected through specific "red flags". However, in elderly patients, extracardiac manifestations may be subtle or misattributed to other diseases or the aging process, complicating the clinical diagnosis. In such cases, genetic testing becomes essential for achieving an accurate diagnosis and guiding specific treatment strategies. Screening younger relatives for genetic predispositions offers additional benefits in the era of emerging novel therapeutic technologies. In this study, we present comprehensive genetic and clinical characterization of three cases of HCM mimics, including amyloidosis, Fabry disease (FD), and desminopathy caused by TTR p.V50M, GLA p.N215S, and DES p.R355* PNVs, respectively. We also provide a brief review of the literature addressing the diagnostic challenges of associated with these rare conditions.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy

